Aspiriant Holdings S3’s Oracle ORCL Stock Holding History

Aspiriant Holdings S3’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$2.24M	Sell	61,205 -1,220	-2%	-$46.6K	0.96%	41
2015 Q3	$2.25M	Sell	62,425 -1,790	-3%	-$68.8K	1.04%	39
2015 Q2	$2.59M	Sell	64,215 -35,007	-35%	-$1.52M	1.03%	40
2015 Q1	$4.28M	Sell	99,222 -2,775	-3%	-$120K	1.7%	22
2014 Q4	$4.59M	Sell	101,997 -1,377	-1%	-$56K	1.89%	16
2014 Q3	$3.96M	Sell	103,374 -360	-0.3%	-$14.6K	1.59%	23
2014 Q2	$4.2M	Sell	103,734 -1,130	-1%	-$46.5K	1.67%	19
2014 Q1	$4.29M	Sell	104,864 -6,220	-6%	-$237K	1.8%	16
2013 Q4	$4.25M	Sell	111,084 -2,349	-2%	-$80.7K	1.67%	24
2013 Q3	$3.76M	Buy	113,433 +1,822	+2%	+$59.1K	1.59%	28
2013 Q2	$3.43M	Buy	+111,611	New	+$3.7M	1.55%	31

Other funds holding ORCL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LTI

Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Eagle Capital Management (New York) New York $29.8B AUM 12.13% 1-Year Est. Return

Aspiriant Holdings S3's ORCL Position: Q4 2015 in Review

Aspiriant Holdings S3 reduced its Oracle (ORCL) stake by 2% in Q4 2015, selling an estimated $46.6K and leaving 61,205 shares worth $2.24M. The position accounts for 0.96% of the portfolio, ranked #41.

Aspiriant Holdings S3 first reported a position in ORCL in Q2 2013 and has held it in 11 quarters since. The position peaked at $4.59M in Q4 2014. 1,491 funds tracked by Wall St. Rank hold ORCL as of Q4 2015.

Aspiriant Holdings S3 held 61,205 shares of Oracle worth $2.24M as of Q4 2015.
Aspiriant Holdings S3 sold 1,220 Oracle shares in Q4 2015, an estimated $46.6K.
Oracle made up 0.96% of Aspiriant Holdings S3's portfolio in Q4 2015, its #41 holding.
Aspiriant Holdings S3 first reported a position in Oracle in Q2 2013 and has held it in 11 quarters since.
Aspiriant Holdings S3's Oracle position peaked at $4.59M in Q4 2014.
1,491 funds tracked by Wall St. Rank held Oracle as of Q4 2015.

Based on Aspiriant Holdings S3's 13F filing for Q4 2015, filed 13 Jan 2016.